Effects of ACE inhibitor/ARB therapy and long COVID on kidney disease: a retrospective cohort study using real-world data.

Yue ZhangDjibril M BaKathryn RisherDuanping LiaoLeslie J ParentNasrollah GhahramaniVernon M Chinchilli

Published in: Clinical kidney journal (2024)

ACEI/ARB treatment does not increase the incidence of CKD or AKI, regardless of long COVID status. However, long COVID itself is associated with increasing risks of kidney diseases and all-cause mortality.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
chronic kidney disease
angiotensin ii
angiotensin converting enzyme
risk assessment
combination therapy
deep learning
data analysis
cell therapy